Republished: Aneurysmal wall imaging in a case of cortical superficial siderosis and multiple unruptured aneurysms

We report a case of interhemispheric and bifrontal cortical superficial siderosis in association with two intracranial aneurysms. The patient had no clinical history suggestive of aneurysm rupture, no feature of amyloid angiopathy or other apparent etiology for cortical siderosis. We performed high resolution brain MRI with dark blood T1 sequences before and after IV contrast injection. An anterior communicating aneurysm showed partial wall enhancement on the posterior wall whereas a left posterior communicating aneurysm did not. In the light of recent reports of the association of wall enhancement with unstable aneurysms, we considered wall enhancement to be a marker of inflammation and remodeling of the aneurysm wall, resulting in chronic hemorrhagic suffusion in the subarachnoid spaces. To our knowledge, this is the first report offering proof for a possible link between apparently unruptured aneurysms and cortical siderosis.

Download Full-text

Stopping “transient ischemic attacks” by antiplatelet withdrawal

Neurological Research and Practice ◽

10.1186/s42466-021-00117-0 ◽

2021 ◽

Vol 3 (1) ◽

Author(s):

Lina Palaiodimou ◽

Aikaterini Theodorou ◽

Stefanos Lachanis ◽

George P. Paraskevas ◽

Matilda Papathanasiou ◽

...

Keyword(s):

Differential Diagnosis ◽

Cerebral Amyloid Angiopathy ◽

Brain Mri ◽

Superficial Siderosis ◽

Amyloid Angiopathy ◽

Perivascular Spaces ◽

The Past ◽

Cerebral Amyloid ◽

Ischemic Attack ◽

Cortical Superficial Siderosis

Abstract Introduction Transient ischemic attack (TIA) is considered to be an important risk factor for the development of ischemic stroke and requires complete etiopathogenic evaluation and prompt initiation of secondary prevention treatment. In addition, an accurate differential diagnosis should be performed in order to exclude other disorders mimicking TIA. Methods In this case report, we describe the clinical and neuroimaging evaluation and the differential diagnosis of a patient with suspected crescendo TIAs. Results A 79-year-old man presented with recurrent episodes of right-sided numbness over the past 7 months, despite different single and dual antiplatelet therapies that were sequentially prescribed for suspected TIAs. Brain MRI revealed cortical superficial siderosis, symmetrical periventricular leukoencephalopathy and enlarged perivascular spaces. Cerebral amyloid angiopathy was considered in the differential diagnosis of the patient. Antiplatelet withdrawal was recommended and led to complete remission of the patient’s transient focal neurological episodes (TFNE) that were initially misdiagnosed as TIAs. Discussion Cortical superficial siderosis has been implicated as a key neuroimaging feature of cerebral amyloid angiopathy, a diagnosis which can be supported by the additional radiological findings of symmetrical white matter hyperintensities and enlarged perivascular spaces. Antiplatelet treatment in patients with cortical superficial siderosis may increase the frequency and severity of TFNE, while it increases exponentially the risk of intracerebral hemorrhage. The present case highlights that recognition of cortical superficial siderosis is crucial in the management of patients presenting with transient focal neurological symptoms that can be misdiagnosed as recurrent TIAs.

Download Full-text

Cortical Superficial Siderosis and Risk of Bleeding after Thrombolysis for Ischemic Stroke

Cerebrovascular Diseases ◽

10.1159/000439184 ◽

2015 ◽

Vol 40 (3-4) ◽

pp. 191-197 ◽

Cited By ~ 6

Author(s):

Thomas Gattringer ◽

Sebastian Eppinger ◽

Markus Beitzke ◽

Gerit Wuensch ◽

Kurt Niederkorn ◽

...

Keyword(s):

Ischemic Stroke ◽

Clinical Data ◽

Brain Mri ◽

Tertiary Care ◽

Medical Documentation ◽

Superficial Siderosis ◽

Amyloid Angiopathy ◽

Stroke Patients ◽

Cerebral Mri ◽

Cortical Superficial Siderosis

Background: Cortical superficial siderosis (CSS) is a neuroimaging marker of cerebral amyloid angiopathy and has been associated with a high risk for early subsequent major intracranial hemorrhage (ICH). Therefore, many experts recommend withholding of antithrombotic medication to patients with CSS. In this study, we sought to investigate the prevalence of CSS and the associated risk of ICH in the setting of intravenous thrombolysis (IVT) for ischemic stroke. Methods: We retrospectively searched the medical documentation system of our primary and tertiary care university clinic for all patients with ischemic stroke that received IVT from 2009 to December 2014. All available imaging data were reviewed in a standardized manner and blinded to any clinical data for the presence of CSS and ICH. CSS was defined as linear signal loss along the cerebral cortex on gradient echo T2*-weighted sequences. A stroke neurologist, who was blinded to the neuroimaging data, extracted the corresponding clinical data including follow-up information. Results: We identified 298 patients that received IVT and had undergone brain MRI (mean age 67.6 ± 12.6 years, 59.4% male). Cerebral MRI was performed in 116 patients (38.9%) before and in 182 patients (61.1%) after IVT (median time from stroke symptom onset to MRI: 1 day; range 0-7 days). Only 3 patients (2 females and 1 male aged 90, 76 and 73 years, respectively) had CSS (1%). All of them had a middle cerebral artery (MCA) stroke with a corresponding vessel occlusion. The 76-year-old female patient had extensive CSS and numerous cerebral microbleeds and received another IVT treatment for recurrent MCA stroke 8 months after the first event. After both IVTs, she had clinically asymptomatic small ICH outside the ischemic infarct and distant from CSS. The 2 other patients had only mild to moderate CSS and did not experience any ICH on postthrombolytic imaging. Conclusions: The prevalence of CSS in a clinical cohort of stroke patients that received IVT was low and thus does not appear to pose a substantial risk for symptomatic ICH although this may occur in individual patients. However, such analysis also needs to be extended to the very old stroke patients in whom IVT is increasingly used.

Download Full-text

Cortical superficial siderosis in the general population: The Framingham Heart and Rotterdam studies

International Journal of Stroke ◽

10.1177/1747493020984559 ◽

2021 ◽

pp. 174749302098455

Author(s):

Ashkan Shoamanesh ◽

Saloua Akoudad ◽

Jayandra J. Himali ◽

Alexa S. Beiser ◽

Charles DeCarli ◽

...

Keyword(s):

General Population ◽

Intracerebral Hemorrhage ◽

Cerebral Amyloid Angiopathy ◽

Brain Mri ◽

Community Dwelling ◽

Superficial Siderosis ◽

Amyloid Angiopathy ◽

Supporting Evidence ◽

Cerebral Amyloid ◽

Cortical Superficial Siderosis

Objective We aimed to characterize cortical superficial siderosis, its determinants and sequel, in community-dwelling older adults. Methods The sample consisted of Framingham ( n = 1724; 2000–2009) and Rotterdam ( n = 4325; 2005–2013) study participants who underwent brain MRI. In pooled individual-level analysis, we compared baseline characteristics in patients with cortical superficial siderosis to two reference groups: (i) persons without hemorrhagic MRI markers of cerebral amyloid angiopathy (no cortical superficial siderosis and no microbleeds) and (ii) those with presumed cerebral amyloid angiopathy based on the presence of strictly lobar microbleeds but without cortical superficial siderosis. Results Among a total of 6049 participants, 4846 did not have any microbleeds or cortical superficial siderosis (80%), 401 had deep/mixed microbleeds (6.6%), 776 had strictly lobar microbleeds without cortical superficial siderosis (12.8%) and 26 had cortical superficial siderosis with/without microbleeds (0.43%). In comparison to participants without microbleeds or cortical superficial siderosis and to those with strictly lobar microbleeds but without cortical superficial siderosis, participants with cortical superficial siderosis were older (OR 1.09 per year, 95% CI 1.05, 1.14; p < 0.001 and 1.04, 95% CI 1.00, 1.09; p = 0.058, respectively), had overrepresentation of the APOE ɛ4 allele (5.19, 2.04, 13.25; p = 0.001 and 3.47, 1.35, 8.92; p = 0.01), and greater prevalence of intracerebral hemorrhage (72.57, 9.12, 577.49; p < 0.001 and 81.49, 3.40, >999.99; p = 0.006). During a mean follow-up of 5.6 years, 42.4% participants with cortical superficial siderosis had a stroke (five intracerebral hemorrhage, two ischemic strokes and four undetermined strokes), 19.2% had transient neurological deficits and 3.8% developed incident dementia. Conclusion Our study adds supporting evidence to the association between cortical superficial siderosis and cerebral amyloid angiopathy within the general population. Community-dwelling persons with cortical superficial siderosis may be at high risk for intracerebral hemorrhage and future neurological events.

Download Full-text

Abstract 120: Cortical Superficial Siderosis in Community-dwelling Subjects: The Framingham Heart and Rotterdam Studies

Stroke ◽

10.1161/str.47.suppl_1.120 ◽

2016 ◽

Vol 47 (suppl_1) ◽

Author(s):

Ashkan Shoamanesh ◽

Saloua Akoudad ◽

Jayandra H Himali ◽

Alexa S Beiser ◽

Charles DeCarli ◽

...

Keyword(s):

Brain Mri ◽

Large Population ◽

Apoe Genotype ◽

Community Dwelling ◽

White Matter Hyperintensity ◽

Superficial Siderosis ◽

Amyloid Angiopathy ◽

Cross Sectional ◽

Increased Risk ◽

Cortical Superficial Siderosis

Background: Cortical superficial siderosis (cSS) is increasingly recognized as an imaging marker of cerebral amyloid angiopathy (CAA) in clinical settings. In these hospital-based cohorts, cSS seems to be a robust indicator of increased risk of future intracerebral hemorrhage (ICH). cSS is also described in community-dwelling individuals, but current understanding of underlying pathology and prognostic implications in this setting is limited. We characterized cSS, its determinants and consequences, compared with another MRI marker of CAA (lobar cerebral microbleeds [CMBs]) in community-dwelling older adults by combining individual-level data from two large population cohorts. Methods: We evaluated cSS in Framingham Original/Offspring Cohort and Rotterdam Study participants ≥ 55 years of age who underwent brain MRI allowing for cSS and CMB detection. In cross-sectional analysis, we compared vascular risk factors/medications, MRI markers of interest, apolipoprotein E (APOE) genotypes (ε3/ε3 as control), and clinical outcomes (ICH, ischemic stroke, transient ischemic attack, and mild cognitive impairment) amongst participants with cSS and those without cSS/CMBs, as well as individuals with strictly lobar CMBs (without cSS). Results: cSS was present in 0.4% (26) of 6049 participants and strictly lobar CMBs in 13% (776). In comparison to participants with neither cSS nor CMBs and to those with strictly lobar CMBs, participants with cSS were older (OR per year increase 1.1, 95% CI 1.1-1.1 and 1.1, 1.0-1.1, respectively), and had overrepresentation of APOE ε4 (at least 1 ε4 allele; age/sex adjusted OR 5.23, 2.1-13.3 and 3.5, 1.4-9.0), and ICH (42, 7-251 and 31, 3.8-253). There also existed a trend toward overrepresentation of the APOE ε2 allele in participants with cSS (2.8, 0.9-8.8, p=0.08 and 2.7, 0.8-8.5, p=0.10). The association with ICH withstood additional adjustment for white matter hyperintensity volume and lacunes on MRI. Conclusions: In this large population-based study of cSS, the prevalence of cSS was low but presence of cSS was more strongly associated with markers of CAA, such as APOE genotype and ICH, than presence of lobar microbleeds without cSS, suggesting that cSS may reflect advanced CAA even in community-dwelling subjects.

Download Full-text

P4-196: Clinical Impacts of Cortical Superficial Siderosis in Patients With Clinically Diagnosed Cerebral Amyloid Angiopathy

Alzheimer s & Dementia ◽

10.1016/j.jalz.2016.06.2288 ◽

2016 ◽

Vol 12 ◽

pp. P1099-P1099

Author(s):

Young Kyoung Jang ◽

Hee Jin Kim ◽

Yeo Jin Kim ◽

Jin San Lee ◽

Juyoun Lee ◽

...

Keyword(s):

Cerebral Amyloid Angiopathy ◽

Superficial Siderosis ◽

Amyloid Angiopathy ◽

Cerebral Amyloid ◽

Cortical Superficial Siderosis

Download Full-text

Cortical superficial siderosis and bleeding risk in cerebral amyloid angiopathy

Neurology ◽

10.1212/wnl.0000000000008590 ◽

2019 ◽

Vol 93 (24) ◽

pp. e2192-e2202 ◽

Cited By ~ 5

Author(s):

Andreas Charidimou ◽

Gregoire Boulouis ◽

Steven M. Greenberg ◽

Anand Viswanathan

Keyword(s):

Cerebral Amyloid Angiopathy ◽

Meta Analysis ◽

Bleeding Risk ◽

Superficial Siderosis ◽

Amyloid Angiopathy ◽

Class Iii ◽

Cerebral Amyloid ◽

T2 Mri ◽

Cortical Superficial Siderosis

ObjectiveTo assess the association of cortical superficial siderosis (cSS) presence and extent with future bleeding risk in cerebral amyloid angiopathy (CAA).MethodsThis was a meta-analysis of clinical cohorts of symptomatic patients with CAA who had T2*-MRI at baseline and clinical follow-up for future intracerebral hemorrhage (ICH). We pooled data in a 2-stage meta-analysis using random effects models. Covariate-adjusted hazard ratios (adjHR) from multivariable Cox proportional hazard models were used.ResultsWe included data from 6 eligible studies (n = 1,239). cSS pooled prevalence was 34% (95% confidence interval [CI] 26%–41%; I2 87.94%; p < 0.001): focal cSS prevalence was 14% (95% CI 12%–16%; I2 6.75%; p = 0.37), and disseminated cSS prevalence was 20% (95% CI 13%–26%; I2 90.39%; p < 0.001). During a mean follow-up of 3.1 years (range 1–4 years), 162/1,239 patients experienced a symptomatic ICH-pooled incidence rate 6.9% per year (95% CI 3.9%–9.8% per year; I2 83%; p < 0.001). ICH incidence rates per year according to cSS status were 3.9% (95% CI 1.7%–6.1%; I2 70%; p = 0.018) for patients without cSS, 11.1% (95% CI 7%–15.2%; I2 56.8%; p = 0.074) for cSS presence, 9.1% (95% CI 5.5%–12.8%; I2 0%; p = 0.994) for focal cSS, and 12.5% (95% CI 5.3%–19.7%; I2 73.2%; p = 0.011) for disseminated cSS. In adjusted pooled analysis, any cSS presence was independently associated with increased future ICH risk (adjHR 2.14; 95% CI 1.19–3.85; p < 0.0001). Focal cSS was linked with ICH risk (adjHR 2.11; 95% CI 1.31–2.41; p = 0.002), while disseminated cSS conferred the strongest bleeding risk (adjHR 4.28; 95% CI 2.91–6.30; p < 0.0001).ConclusionIn patients with CAA, cSS presence and extent are the most important MRI prognostic risk factors for future ICH, likely useful in treatment planning.Classification of evidenceThis study provides Class III evidence that in symptomatic CAA survivors with baseline T2*-MRI, cSS (particularly if disseminated, i.e., affecting >3 sulci) increases the risk of future ICH.

Download Full-text

Aneurysmal wall imaging in a case of cortical superficial siderosis and multiple unruptured aneurysms

BMJ Case Reports ◽

10.1136/bcr-2016-012680 ◽

2016 ◽

pp. bcr2016012680 ◽

Cited By ~ 1

Author(s):

Bertrand Yalo ◽

Raoul Pop ◽

Ielyzaveta Zinchenko ◽

Mihaela Diaconu ◽

Salvatore Chibbaro ◽

...

Keyword(s):

Superficial Siderosis ◽

Unruptured Aneurysms ◽

Aneurysmal Wall ◽

Cortical Superficial Siderosis ◽

Wall Imaging

Download Full-text

Clinical and radiological differences between patients with probable cerebral amyloid angiopathy and mixed cerebral microbleeds

Journal of Neurology ◽

10.1007/s00415-020-10038-8 ◽

2020 ◽

Vol 267 (12) ◽

pp. 3602-3608 ◽

Cited By ~ 1

Author(s):

Ulf R. Jensen-Kondering ◽

Caroline Weiler ◽

Patrick Langguth ◽

Naomi Larsen ◽

Charlotte Flüh ◽

...

Keyword(s):

Cerebral Amyloid Angiopathy ◽

Cerebral Microbleeds ◽

Superficial Siderosis ◽

Periventricular White Matter ◽

Amyloid Angiopathy ◽

Imaging Features ◽

Significant Difference ◽

Comprehensive Comparison ◽

Cerebral Amyloid ◽

Cortical Superficial Siderosis

Abstract Background The key imaging features of cerebral amyloid angiopathy (CAA) are lobar, cortical, or cortico-subcortical microbleeds, macrohaemorrhages and cortical superficial siderosis (cSS). In contrast, hypertensive angiopathy is characterized by (micro) haemorrhages in the basal ganglia, thalami, periventricular white matter or the brain stem. Another distinct form of haemorrhagic microangiopathy is mixed cerebral microbleeds (mixed CMB) with features of both CAA and hypertensive angiopathy. The distinction between the two entities (CAA and mixed CMB) is clinically relevant because the risk of haemorrhage and stroke should be well balanced if oral anticoagulation is indicated in CAA patients. We aimed to comprehensively compare these two entities. Methods Patients with probable CAA according to the modified Boston criteria and mixed CMB without macrohaemorrhage were retrospectively identified from our database. Comprehensive comparison regarding clinical and radiological parameters was performed between the two cohorts. Results Patients with CAA were older (78 ± 8 vs. 74 ± 9 years, p = 0.036) and had a higher prevalence of cSS (19% vs. 4%, p = 0.027) but a lower prevalence of lacunes (73% vs. 50%, p = 0.018) and deep lacunes (23% vs. 51%, p = 0.0003) compared to patients with mixed CMB. Logistic regression revealed an association between the presence of deep lacunes and mixed CMB. The other collected parameters did not reveal a significant difference between the two groups. Conclusions CAA and mixed CMB demonstrate radiological differences in the absence of macrohaemorrhages. However, more clinically available biomarkers are needed to elucidate the contribution of CAA and hypertensive angiopathy in mixed CMB patients.

Download Full-text

Cortical superficial siderosis progression in cerebral amyloid angiopathy

Neurology ◽

10.1212/wnl.0000000000009321 ◽

2020 ◽

Vol 94 (17) ◽

pp. e1853-e1865 ◽

Cited By ~ 3

Author(s):

Thanakit Pongpitakmetha ◽

Panagiotis Fotiadis ◽

Marco Pasi ◽

Gregoire Boulouis ◽

Li Xiong ◽

...

Keyword(s):

Logistic Regression ◽

Cerebral Amyloid Angiopathy ◽

Ordinal Scale ◽

Superficial Siderosis ◽

Amyloid Angiopathy ◽

Cox Regression Analysis ◽

Multivariable Logistic Regression ◽

Potential Biomarker ◽

Cerebral Amyloid ◽

Cortical Superficial Siderosis

ObjectiveTo investigate the prevalence, predictors, and clinical relevance of cortical superficial siderosis (cSS) progression in cerebral amyloid angiopathy (CAA).MethodsConsecutive patients with symptomatic CAA meeting Boston criteria in a prospective cohort underwent baseline and follow-up MRI within 1 year. cSS progression was evaluated on an ordinal scale and categorized into mild (score 1–2 = cSS extension within an already present cSS focus or appearance of 1 new cSS focus) and severe progression (score 3–4 = appearance of ≥2 new cSS foci). Binominal and ordinal multivariable logistic regression were used to determine cSS progression predictors. We investigated future lobar intracerebral hemorrhage (ICH) risk in survival analysis models.ResultsWe included 79 patients with CAA (mean age, 69.2 years), 56 (71%) with lobar ICH at baseline. cSS progression was detected in 23 (29%) patients: 15 (19%) patients had mild and 8 (10%) severe progression. In binominal multivariable logistic regression, ICH presence (odds ratio [OR], 7.54; 95% confidence interval [CI], 1.75–53.52; p = 0.016) and baseline cSS (OR, 10.41; 95% CI, 2.84–52.83; p = 0.001) were independent predictors of cSS progression. In similar models, presence of disseminated (but not focal) cSS at baseline (OR, 5.58; 95% CI, 1.81–19.41; p = 0.004) was an independent predictor of cSS progression. Results were similar in ordinal multivariable logistic regression models. In multivariable Cox regression analysis, severe cSS progression was independently associated with increased future ICH risk (HR, 5.90; 95% CI, 1.30–26.68; p = 0.021).ConclusionscSS evolution on MRI is common in patients with symptomatic CAA and might be a potential biomarker for assessing disease severity and future ICH risk. External validation of these findings is warranted.

Download Full-text

Convexity subarachnoid hemorrhage in lobar intracerebral hemorrhage

Neurology ◽

10.1212/wnl.0000000000009036 ◽

2020 ◽

Vol 94 (9) ◽

pp. e968-e977 ◽

Cited By ~ 1

Author(s):

Nicolas Raposo ◽

Andreas Charidimou ◽

Duangnapa Roongpiboonsopit ◽

Michelle Onyekaba ◽

M. Edip Gurol ◽

...

Keyword(s):

Subarachnoid Hemorrhage ◽

Intracerebral Hemorrhage ◽

Regression Models ◽

Cox Regression ◽

Bleeding Risk ◽

Superficial Siderosis ◽

Amyloid Angiopathy ◽

Increased Risk ◽

Cortical Superficial Siderosis

ObjectiveTo investigate whether acute convexity subarachnoid hemorrhage (cSAH) associated with acute lobar intracerebral hemorrhage (ICH) increases the risk of ICH recurrence in patients with cerebral amyloid angiopathy (CAA).MethodsWe analyzed data from a prospective cohort of consecutive survivors of acute spontaneous lobar ICH fulfilling the Boston criteria for possible or probable CAA (CAA-ICH). We analyzed baseline clinical and MRI data, including cSAH (categorized as adjacent or remote from ICH on a standardized scale), cortical superficial siderosis (cSS), and other CAA MRI markers. Multivariable Cox regression models were used to assess the association between cSAH and recurrent symptomatic ICH during follow-up.ResultsWe included 261 CAA-ICH survivors (mean age 76.2 ± 8.7 years). Of them, 166 (63.6%, 95% confidence interval [CI] 57.7%–69.5%) had cSAH on baseline MRI. During a median follow-up of 28.3 (interquartile range 7.2–57.0) months, 54 (20.7%) patients experienced a recurrent lobar ICH. In Cox regression, any cSAH, adjacent cSAH, and remote cSAH were independent predictors of recurrent ICH after adjustment for other confounders, including cSS. Incidence rate of recurrent ICH in patients with cSAH was 9.9 per 100 person-years (95% CI 7.3–13.0) compared with 1.2 per 100 person-years (95% CI 0.3–3.2) in those without cSAH (adjusted hazard ratio 7.5, 95% CI 2.6–21.1).ConclusionIn patients with CAA-related acute ICH, cSAH (adjacent or remote from lobar ICH) is commonly observed and heralds an increased risk of recurrent ICH. cSAH may help stratify bleeding risk and should be assessed along with cSS for prognosis and clinical management.

Download Full-text